NICE opts not to recommend Opdivo for head and neck cancer - BioPharma Dive

NICE opts not to recommend Opdivo for head and neck cancer BioPharma Dive "This decision denies patients a genuine breakthrough treatment that makes a real difference for people with relapsed metastatic head and neck cancer. It is another example, and a particularly stark one, of an innovative cancer therapy not being made ...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2otP4y9
via IFTTT